uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
Show others and affiliations
2014 (English)In: PLoS ONE, ISSN 1932-6203, Vol. 9, no 1, e85040- p.Article in journal (Refereed) Published
Abstract [en]

Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens - genetically governed antigenic determinants - at all given steps of MSC-therapy, from cell isolation and preparation for clinical use, to final recipient outcome. We found that clinical MSCs do not inherently express or upregulate ABO blood group antigens after inflammatory challenge or in vitro differentiation. Although antigen adsorption from standard culture supplements was minimal, MSCs adsorbed small quantities of ABO antigen from fresh human AB plasma (ABP), dependent on antigen concentration and adsorption time. Compared to cells washed in non-immunogenic human serum albumin (HSA), MSCs washed with ABP elicited stronger blood responses after exposure to blood from healthy O donors in vitro, containing high titers of ABO antibodies. Clinical evaluation of hematopoietic stem cell transplant (HSCT) recipients found only very low titers of anti-A/B agglutination in these strongly immunocompromised patients at the time of MSC treatment. Patient analysis revealed a trend for lower clinical response in blood group O recipients treated with ABP-exposed MSC products, but not with HSA-exposed products. We conclude, that clinical grade MSCs are ABO-neutral, but the ABP used for washing and infusion of MSCs can contaminate the cells with immunogenic ABO substance and should therefore be substituted by non-immunogenic HSA, particularly when cells are given to immunocompentent individuals.

Place, publisher, year, edition, pages
2014. Vol. 9, no 1, e85040- p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-218949DOI: 10.1371/journal.pone.0085040ISI: 000329922500034OAI: oai:DiVA.org:uu-218949DiVA: diva2:699314
Available from: 2014-02-27 Created: 2014-02-20 Last updated: 2014-02-27Bibliographically approved

Open Access in DiVA

fulltext(1631 kB)182 downloads
File information
File name FULLTEXT01.pdfFile size 1631 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Stenbeck-Funke, LillemorTeramura, YujiNilsson, Bo
By organisation
Department of Immunology, Genetics and PathologyClinical Immunology
In the same journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 182 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 312 hits
ReferencesLink to record
Permanent link

Direct link